Choate Investment Advisors Astrazeneca PLC Transaction History
Choate Investment Advisors
- $3.89 Billion
- Q3 2024
A detailed history of Choate Investment Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Choate Investment Advisors holds 5,820 shares of AZN stock, worth $367,998. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,820
Previous 5,263
10.58%
Holding current value
$367,998
Previous $410,000
10.49%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$3.98 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.65 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.36 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.33 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.22 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $196B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...